NIAID awards grant to Kephera Diagnostics for point-of-care test for Neurocysticercosis
NIAID awards grant to Kephera Diagnostics for point-of-care test for Neurocysticercosis Framingham, MA – January 13, 2020. Kephera Diagnostics has been awarded a two-year, $600,000 Phase I SBIR grant from the National Institute of Allergy and Infectious Diseases (NIAID) to develop a point-of-care test for Neurocysticercosis, the company announced today. Neurocysticercosis is an infection of…